Hong Kong shares its public health bona fides with global investors
For a city with a strong reputation for reinvention, focusing on medical technology is a logical step for economic growth and patient care
Chief Executive John Lee Ka-chiu said the city’s strengths are magnified by its core position in the Greater Bay Area. In pursuit of medical innovation, Lee said, Hong Kong “complements the strategies set out in the national 15th five-year plan”. Secretary for Health Lo Chung-mau highlighted the city’s unique role in strengthening global pandemic preparedness and response, as the world monitors a deadly hantavirus outbreak linked to the cruise ship MV Hondius.
Lo said the Covid-19 pandemic carried a “sobering lesson” about how no health system, however advanced, can stand alone against a pandemic. He said that when the next pandemic emerges, “collective survival will depend not on walls, but on bridges”. Hong Kong has strengthened its preparedness, including by setting up an emerging disease research fund to translate insights into real-world strategies.
Hong Kong’s efforts to improve care for its residents were also explored during the three-day Hospital Authority conference, which drew more than 9,000 local, mainland and overseas healthcare professionals and academics.
Authority chief executive Libby Lee Ha-yun said Hong Kong’s first five-year plan for 2026 to 2030 includes measures to streamline services to avoid competing clinical demands, scale up specialised centres and deploy AI-assisted diagnostics to support radiologists.
Such projects are to be welcomed in a city where the healthcare system has been praised for quality, yet a cause of great concern is that it may be overburdened by an ageing society and staff shortages.